药物对比
Miglitol vs Vildagliptin
Miglitol（α-葡萄糖苷酶抑制剂）减缓碳水化合物吸收；Vildagliptin（DPP-4抑制剂）促进胰岛素分泌。两者均为口服的2型糖尿病治疗药物。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes not responding adequately to metformin or sulfonylureas may require comparison of miglitol and vildagliptin.
结论
Miglitol and Vildagliptin are both viable oral antidiabetic medications, but the optimal choice varies based on patient-specific factors including mechanism of action and comorbidities.
全部药物对比